TPP1 and Parkinson disease: TPP1 expression was elevated in neuromelanin-positive dopaminergic neurons in late-stage PD, and TPP1 knockdown increased α-synuclein aggregation, consistent with a protective role further supported by computational modeling of the α-synuclein–TPP1 interface.